Billing options

OneOme’s strives to provide cost-effective pharmacogenomic testing and tools for providers across the globe. That’s why we’ve created a billing process that supports different payment options, depending on how the test is ordered.

Payment options include:

  • Patient self pay (U.S. only)

  • Institutional billing

  • Insurance billing (U.S. only)

Our client services team can help you identify the best billing option for your scenario. Contact us for more information.

Patient self-pay (U.S. only)

For tests ordered by a patient’s provider, patients may pay for the test as part of the provider’s order process or they can choose to have OneOme reach out to collect payment afterwards. OneOme accepts payments from all major credit cards and HSA accounts. In addition, we offer interest-free payment plans when needed. Please contact us for more information.

Please note that a patient’s sample will not be processed until payment is collected or a payment plan has been established.

For RightMed Tests ordered through the independent provider network, OneOme accepts payment from credit cards and HSA accounts (insurance billing is not available for this option).

Institutional billing

Institutional billing is available with or without a contract, but most institutions choose to secure contracted pricing. Testing is not invoiced until a report has been delivered. We offer a variety of payment options including check, credit card, or wire transfer. Please contact us for more information.

Insurance billing

Our goal is to provide patients the lowest cost option available to them. Depending on a patient’s insurance, their maximum out-of-pocket cost may vary.

Private insurance billing process

  • OneOme reviews the patient’s insurance information to make sure it is complete and accurate.
  • If a claim is submitted, the patient will receive an explanation of benefits (EOB) from their insurance company in the mail. The EOB is NOT a bill, but an explanation of what was covered.
  • If coverage is denied or only part of the test is covered, OneOme may appeal the decision on behalf of the patient.
  • After a final coverage decision from insurance is made, a patient may receive an invoice from OneOme for any deductibles, coinsurance, copayments, and for services deemed non-covered or ineligible under their insurance policy.

OneOme’s tests were developed and their performance characteristics have been determined by OneOme, LLC, a clinical laboratory located at 807 Broadway Street NE, Suite 100 Minneapolis, MN 55413. They have not been cleared or approved by the U.S. Food and Drug Administration. OneOme is regulated under CLIA-88 as qualified to perform high-complexity testing. These tests are used for clinical purposes and should not be regarded as investigational or for research.

Have questions about billing?

Dedicated experts are available to answer your questions. Speak with a client service representative today.